Line 2,217: |
Line 2,217: |
| |}<br /> | | |}<br /> |
| | | |
− | ==WHO Classification of Tumours of the Central Nervous System Content== | + | ==WHO Central Nervous System Tumours (5th ed.) Content== |
| {| class="wikitable" | | {| class="wikitable" |
| |- | | |- |
Line 2,228: |
Line 2,228: |
| !'''Notes''' | | !'''Notes''' |
| |- | | |- |
− | |Medulloblastoma, WNT-activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City | + | | Astrocytoma, IDH-mutant||Disease|| |
− | |9/20/21
| |
− | |
| |
− | |COMPLETE
| |
− | |
| |
− | |Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
| |
− | |9/22/2022
| |
− | |2021 template added
| |
− | |-
| |
− | |Paediatric-Type Diffuse High-Grade Gliomas
| |
− | |Overview
| |
| | | | | |
| | | | | |
Line 2,246: |
Line 2,236: |
| | | | | |
| | | | | |
− | |2021 template added
| |
| |- | | |- |
− | |Diffuse Midline Glioma, H3 K27-Altered | + | | Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| |
− | |Disease | |
− | |Laveniya Satgunaseelan (Linda Cooley - previous version) | |
| | | | | |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |Laveniya Satgunaseelan (LS)
| |
| | | | | |
− | |2021 template added
| |
− | |-
| |
− | |Diffuse Hemispheric Glioma, H3 G34-Mutant
| |
− | |Disease
| |
− | |Xiaolin (Lynn) Hu
| |
− | |2/21/2022
| |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |LS
| |
| | | | | |
− | |2021 template added
| |
| |- | | |- |
− | |Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype | + | | Glioblastoma, IDH-wildtype||Disease|| |
− | |Disease | |
| | | | | |
| | | | | |
Line 2,279: |
Line 2,254: |
| | | | | |
| | | | | |
− | |2021 template added
| |
| |- | | |- |
− | |Infant-Type Hemispheric Glioma | + | | Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| |
− | |Disease | |
| | | | | |
| | | | | |
Line 2,290: |
Line 2,263: |
| | | | | |
| | | | | |
− | |2021 template added
| |
| |- | | |- |
− | |Astrocytoma, IDH-Mutant | + | | Angiocentric glioma||Disease|| |
− | |Disease | + | | |
− | |Riley Lochner (trainee), Shashi Shetty (mentor) | |
− | |3/3/2022 | |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |LS
| |
| | | | | |
− | |2021 template added
| |
− | |-
| |
− | |Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
| |
− | |Disease
| |
− | |Riley Lochner (trainee), Shashi Shetty (mentor)
| |
− | |3/3/2022
| |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |LS
| |
| | | | | |
− | |2021 template added
| |
| |- | | |- |
− | |Ganglioglioma | + | | Polymorphous low-grade neuroepithelial tumour of the young||Disease|| |
− | |Disease | + | | |
− | |Leila Moayed-Aloei | |
− | |6/30/2022 | |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |LS
| |
| | | | | |
− | |2021 template added
| |
− | |-
| |
− | |Pilocytic Astrocytoma
| |
− | |Disease
| |
− | |Jeremy Pulvers
| |
− | |9/13/2022
| |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |LS
| |
| | | | | |
− | |2021 template added
| |
− | |-
| |
− | |}<br />
| |
− |
| |
− | ==WHO Classification of Soft Tissue and Bone Tumours Content==
| |
− | {| class="wikitable"
| |
− | |-
| |
− | !'''Disease'''!!'''Page Type'''!!'''Author'''
| |
− | !'''Date Assigned to Author'''
| |
− | !'''Target Completion Date'''
| |
− | !'''Author Content (Pending or Complete)'''
| |
− | !'''Date Completed by Author'''!!'''Associate Editor'''
| |
− | !'''Date of Last Editor Review'''
| |
− | !'''Notes'''
| |
| |- | | |- |
− | |NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD | + | | Diffuse low-grade glioma, MAPK pathway-altered ||Disease|| |
− | |2/20/2022
| |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |Alanna Church
| |
| | | | | |
| | | | | |
− | |-
| |
− | |}<br />
| |
− |
| |
− | ==WHO Classification of Tumours of Breast Tumours Content==
| |
− | {| class="wikitable"
| |
− | |-
| |
− | !'''Disease'''!!'''Page Type'''!!'''Author'''
| |
− | !'''Date Assigned to Author'''
| |
− | !'''Target Completion Date'''
| |
− | !'''Author Content (Pending or Complete)'''
| |
− | !'''Date Completed by Author'''!!'''Associate Editor'''
| |
− | !'''Date of Last Editor Review'''
| |
− | !'''Notes'''
| |
− | |-
| |
− | |Adenoid Cystic Carcinoma
| |
− | |Disease||Katherine Geiersbach
| |
− | |10/12/02022
| |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |Hui Chen
| |
| | | | | |
− | |2021 template added
| |
| |- | | |- |
− | |Secretory Carcinoma | + | | Diffuse midline glioma, H3 K27-altered||Disease|| |
− | |Disease | |
− | |Hui Chen
| |
− | |10/12/2022
| |
− | | | |
− | |PENDING | |
| | | | | |
− | |Katherine Geiersbach
| |
| | | | | |
− | |2021 template added
| |
− | |-
| |
− | |}<br />
| |
− |
| |
− | ==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
| |
− | {| class="wikitable sortable"
| |
− | !'''Gene'''
| |
− | !'''Author'''
| |
− | !'''Date Assigned to Author'''
| |
− | !'''Target Completion Date'''
| |
− | !'''Author Content (Pending or Complete)'''
| |
− | !'''Date Completed by Author'''
| |
− | !'''Associate Editor'''
| |
− | !'''Date of Last Editor Review'''
| |
− | !'''Notes'''
| |
− | |-
| |
− | |BCR
| |
− | |Brian Davis
| |
| | | | | |
| | | | | |
− | |Complete
| |
− | |8/10/18
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |ABL1 | + | | Diffuse hemispheric glioma, H3 G34-mutant||Disease|| |
− | |Brian Davis | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |4/16/19
| |
| | | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |RUNX1
| |
− | |Brian Davis
| |
| | | | | |
| | | | | |
− | |Complete | + | |- |
− | |6/9/19 | + | | Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| |
− | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |RUNX1T1
| |
− | |Brian Davis
| |
| | | | | |
| | | | | |
− | |Complete
| |
− | |5/23/19
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |MYH11 | + | | Infant-type hemispheric glioma||Disease|| |
− | |Brian Davis | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |8/6/18
| |
| | | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |FLT3
| |
− | |Kay Weng Choy
| |
| | | | | |
| | | | | |
− | |Complete | + | |- |
− | | | + | | Pilocytic astrocytoma ||Disease|| |
| | | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |NPM1
| |
− | |Kay Weng Choy
| |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
| + | |- |
| + | | High-grade astrocytoma with piloid features||Disease|| |
| | | | | |
| | | | | |
− | |-
| |
− | |TP53
| |
− | |Kay Weng Choy
| |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | | Pleomorphic xanthoastrocytoma||Disease|| |
| | | | | |
− | |-
| |
− | |DNMT3A
| |
− | |Kay Weng Choy
| |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,496: |
Line 2,354: |
| | | | | |
| |- | | |- |
− | |CEBPA | + | | Subependymal giant cell astrocytoma||Disease|| |
− | |Gordana | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,506: |
Line 2,363: |
| | | | | |
| |- | | |- |
− | |IDH1 | + | | Chordoid glioma||Disease|| |
− | |Paul De Fazio | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,516: |
Line 2,372: |
| | | | | |
| |- | | |- |
− | |IDH2 | + | | Astroblastoma, MN1-altered||Disease|| |
− | |Paul De Fazio | + | | |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
Line 2,526: |
Line 2,381: |
| | | | | |
| |- | | |- |
− | |PML | + | | Ganglioglioma||Disease|| |
− | |Brian Davis | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |12/5/18
| |
| | | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |RARA
| |
− | |Brian Davis
| |
| | | | | |
| | | | | |
− | |Complete | + | |- |
− | |8/3/18 | + | | Gangliocytoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |ETV6
| |
− | |Brian Davis
| |
| | | | | |
| | | | | |
− | |Complete
| |
− | |6/9/19
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | |KIT | + | | Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| |
− | |Brian Davis | |
| | | | | |
| | | | | |
− | |Complete
| |
− | |10/1/18
| |
| | | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |CBFB
| |
− | |Brian Davis
| |
| | | | | |
| | | | | |
− | |Complete | + | |- |
− | |8/2/18 | + | | Dysembryoplastic neuroepithelial tumour||Disease|| |
− | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |GATA2
| |
− | |Kay Weng Choy
| |
| | | | | |
| | | | | |
− | |Complete
| |
| | | | | |
| | | | | |
| | | | | |
| + | |- |
| + | | Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| |
| | | | | |
− | |-
| |
− | |PTEN
| |
− | |Beth Pitel
| |
| | | | | |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,596: |
Line 2,426: |
| | | | | |
| |- | | |- |
− | |MLTT3 | + | | Papillary glioneuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,604: |
Line 2,434: |
| | | | | |
| | | | | |
| + | |- |
| + | | Rosette-forming glioneuronal tumour||Disease|| |
| | | | | |
− | |-
| |
− | |MECOM
| |
− | |Brian Davis
| |
| | | | | |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,616: |
Line 2,444: |
| | | | | |
| |- | | |- |
− | |FGFR1(FLT2) | + | | Myxoid glioneuronal tumour||Disease|| |
− | |Brian Davis | + | | |
| | | | | |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,626: |
Line 2,453: |
| | | | | |
| |- | | |- |
− | |KMT2A | + | | Diffuse leptomeningeal glioneuronal tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,634: |
Line 2,461: |
| | | | | |
| | | | | |
| + | |- |
| + | | Multinodular and vacuolating neuronal tumour||Disease|| |
| | | | | |
− | |-
| |
− | |DEK
| |
− | |Wahab A. Khan
| |
| | | | | |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,646: |
Line 2,471: |
| | | | | |
| |- | | |- |
− | |NUP214 | + | | Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| |
− | |Wahab A. Khan | + | | |
| | | | | |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,656: |
Line 2,480: |
| | | | | |
| |- | | |- |
− | |RBM15 | + | | Central neurocytoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,666: |
Line 2,489: |
| | | | | |
| |- | | |- |
− | |MKL1 | + | | Extraventricular neurocytoma||Disease|| |
− | | | |
− | | | |
− | | | |
− | |
| |
− | |
| |
− | | | |
| | | | | |
| | | | | |
− | |-
| |
− | |DDX41
| |
− | |Ying Zou
| |
− | |8/7/20
| |
| | | | | |
− | |Pending
| |
| | | | | |
| | | | | |
Line 2,686: |
Line 2,498: |
| | | | | |
| |- | | |- |
− | |ANKRD26 | + | | Cerebellar liponeurocytoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,696: |
Line 2,507: |
| | | | | |
| |- | | |- |
− | |CUX1 | + | | Supratentorial ependymoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,706: |
Line 2,516: |
| | | | | |
| |- | | |- |
− | |TET2 | + | | Supratentorial ependymoma, ZFTA fusion-positive ||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,716: |
Line 2,525: |
| | | | | |
| |- | | |- |
− | |EZH2 | + | | Supratentorial ependymoma, YAP1 fusion-positive||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,726: |
Line 2,534: |
| | | | | |
| |- | | |- |
− | |FOXP1 | + | | Posterior fossa ependymoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,736: |
Line 2,543: |
| | | | | |
| |- | | |- |
− | |MYC | + | | Posterior fossa group A (PFA) ependymoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,746: |
Line 2,552: |
| | | | | |
| |- | | |- |
− | |JAK2 | + | | Posterior fossa group B (PFB) ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,754: |
Line 2,560: |
| | | | | |
| | | | | |
| + | |- |
| + | | Spinal ependymoma||Disease|| |
| | | | | |
− | |-
| |
− | |WT1
| |
− | |DONE
| |
| | | | | |
| | | | | |
− | |DONE
| |
| | | | | |
| | | | | |
Line 2,766: |
Line 2,570: |
| | | | | |
| |- | | |- |
− | |CBL | + | | Spinal ependymoma, MYCN-amplified||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,776: |
Line 2,579: |
| | | | | |
| |- | | |- |
− | |NF1 | + | | Myxopapillary ependymoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,786: |
Line 2,588: |
| | | | | |
| |- | | |- |
− | |SUZ12 | + | | Subependymoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,796: |
Line 2,597: |
| | | | | |
| |- | | |- |
− | |ERG | + | | Choroid plexus papilloma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,806: |
Line 2,606: |
| | | | | |
| |- | | |- |
− | |EST2 | + | | Atypical choroid plexus papilloma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,816: |
Line 2,615: |
| | | | | |
| |- | | |- |
− | |RPS14 | + | | Choroid plexus carcinoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,826: |
Line 2,624: |
| | | | | |
| |- | | |- |
− | |RB1 | + | | Medulloblastoma, WNT-activated||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,836: |
Line 2,633: |
| | | | | |
| |- | | |- |
− | |MPL | + | | Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,846: |
Line 2,642: |
| | | | | |
| |- | | |- |
− | |CHGA | + | | Medulloblastoma, SHH-activated and TP53-mutant||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,856: |
Line 2,651: |
| | | | | |
| |- | | |- |
− | |CDH1 | + | | Medulloblastoma, non-WNT/non-SHH||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,866: |
Line 2,660: |
| | | | | |
| |- | | |- |
− | |SRSF2 | + | | Medulloblastoma, histologically defined||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,876: |
Line 2,669: |
| | | | | |
| |- | | |- |
− | |DNMT1 | + | | Atypical teratoid/rhabdoid tumour||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,886: |
Line 2,678: |
| | | | | |
| |- | | |- |
− | |PRDX2 | + | | Cribriform neuroepithelial tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,894: |
Line 2,686: |
| | | | | |
| | | | | |
| + | |- |
| + | | Embryonal tumour with multilayered rosettes||Disease|| |
| | | | | |
− | |-
| |
− | |ASXL1
| |
− | |DONE
| |
| | | | | |
| | | | | |
− | |DONE
| |
| | | | | |
| | | | | |
Line 2,906: |
Line 2,696: |
| | | | | |
| |- | | |- |
− | |MN1 | + | | CNS neuroblastoma, FOXR2-activated||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,916: |
Line 2,705: |
| | | | | |
| |- | | |- |
− | |SF3A1 | + | | CNS tumour with BCOR internal tandem duplication||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,926: |
Line 2,714: |
| | | | | |
| |- | | |- |
− | |EP300 | + | | CNS embryonal tumour NEC/NOS||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,936: |
Line 2,723: |
| | | | | |
| |- | | |- |
− | |JARID2 | + | | Pineocytoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,946: |
Line 2,732: |
| | | | | |
| |- | | |- |
− | |BRCA1 | + | | Pineal parenchymal tumour of intermediate differentiation||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,956: |
Line 2,741: |
| | | | | |
| |- | | |- |
− | |BRCA2 | + | | Pineoblastoma||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,966: |
Line 2,750: |
| | | | | |
| |- | | |- |
− | | | + | | Papillary tumour of the pineal region||Disease|| |
− | | | |
| | | | | |
| | | | | |
Line 2,976: |
Line 2,759: |
| | | | | |
| |- | | |- |
| + | | Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| |
| | | | | |
| | | | | |
Line 2,983: |
Line 2,767: |
| | | | | |
| | | | | |
| + | |- |
| + | | Schwannoma||Disease|| |
| | | | | |
− | |
| |
− | |}
| |
− |
| |
− | ==WHO Central Nervous System Tumours (5th ed.) Content==
| |
− |
| |
− |
| |
− | {| class="wikitable"
| |
− | |-
| |
− | !'''Disease'''!!'''Page Type'''!!'''Author'''
| |
− | !'''Date Assigned to Author'''
| |
− | !'''Target Completion Date'''
| |
− | !'''Author Content (Pending or Complete)'''
| |
− | !'''Date Completed by Author'''!!'''Associate Editor'''
| |
− | !'''Date of Last Editor Review'''
| |
− | !'''Notes'''
| |
− | |-
| |
− | |Astrocytoma, IDH-mutant||Disease||
| |
| | | | | |
| | | | | |
Line 3,008: |
Line 2,777: |
| | | | | |
| |- | | |- |
− | |Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| | + | | Neurofibroma||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Glioblastoma, IDH-wildtype||Disease||
| |
| | | | | |
| | | | | |
Line 3,024: |
Line 2,786: |
| | | | | |
| |- | | |- |
− | |Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| | + | | Perineurioma||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Angiocentric glioma||Disease||
| |
| | | | | |
| | | | | |
Line 3,040: |
Line 2,795: |
| | | | | |
| |- | | |- |
− | |Polymorphous low-grade neuroepithelial tumour of the young||Disease|| | + | | Hybrid nerve sheath tumours||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Diffuse low-grade glioma, MAPK pathway-altered||Disease||
| |
| | | | | |
| | | | | |
Line 3,056: |
Line 2,804: |
| | | | | |
| |- | | |- |
− | |Diffuse midline glioma, H3 K27-altered||Disease|| | + | | Malignant melanotic nerve sheath tumour||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |Diffuse hemispheric glioma, H3 G34-mutant||Disease||
| |
| | | | | |
| | | | | |
Line 3,072: |
Line 2,813: |
| | | | | |
| |- | | |- |
− | |Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| | + | | Malignant peripheral nerve sheath tumour||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Infant-type hemispheric glioma||Disease||
| |
| | | | | |
| | | | | |
Line 3,088: |
Line 2,822: |
| | | | | |
| |- | | |- |
− | |Pilocytic astrocytoma||Disease|| | + | | Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |High-grade astrocytoma with piloid features||Disease||
| |
| | | | | |
| | | | | |
Line 3,104: |
Line 2,831: |
| | | | | |
| |- | | |- |
− | |Pleomorphic xanthoastrocytoma||Disease|| | + | | Meningioma||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Subependymal giant cell astrocytoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,120: |
Line 2,840: |
| | | | | |
| |- | | |- |
− | |Chordoid glioma||Disease|| | + | | Solitary fibrous tumour||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Astroblastoma, MN1-altered||Disease||
| |
| | | | | |
| | | | | |
Line 3,136: |
Line 2,849: |
| | | | | |
| |- | | |- |
− | |Ganglioglioma||Disease|| | + | | Haemangiomas and vascular malformations||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |Gangliocytoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,152: |
Line 2,858: |
| | | | | |
| |- | | |- |
− | |Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| | + | | Haemangioblastoma||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Dysembryoplastic neuroepithelial tumour||Disease||
| |
| | | | | |
| | | | | |
Line 3,168: |
Line 2,867: |
| | | | | |
| |- | | |- |
− | |Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| | + | | Rhabdomyosarcoma||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Papillary glioneuronal tumour||Disease||
| |
| | | | | |
| | | | | |
Line 3,184: |
Line 2,876: |
| | | | | |
| |- | | |- |
− | |Rosette-forming glioneuronal tumour||Disease|| | + | | Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Myxoid glioneuronal tumour||Disease||
| |
| | | | | |
| | | | | |
Line 3,200: |
Line 2,885: |
| | | | | |
| |- | | |- |
− | |Diffuse leptomeningeal glioneuronal tumour||Disease|| | + | | CIC-rearranged sarcoma||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Multinodular and vacuolating neuronal tumour||Disease||
| |
| | | | | |
| | | | | |
Line 3,216: |
Line 2,894: |
| | | | | |
| |- | | |- |
− | |Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| | + | | Primary intracranial sarcoma, DICER1-mutant||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |Central neurocytoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,232: |
Line 2,903: |
| | | | | |
| |- | | |- |
− | |Extraventricular neurocytoma||Disease|| | + | | Ewing sarcoma||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Cerebellar liponeurocytoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,248: |
Line 2,912: |
| | | | | |
| |- | | |- |
− | |Supratentorial ependymoma||Disease|| | + | | Mesenchymal chondrosarcoma||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Supratentorial ependymoma, ZFTA fusion-positive||Disease||
| |
| | | | | |
| | | | | |
Line 3,264: |
Line 2,921: |
| | | | | |
| |- | | |- |
− | |Supratentorial ependymoma, YAP1 fusion-positive||Disease|| | + | | Chondrosarcoma||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Posterior fossa ependymoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,280: |
Line 2,930: |
| | | | | |
| |- | | |- |
− | |Posterior fossa group A (PFA) ependymoma||Disease|| | + | | Chordoma||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Posterior fossa group B (PFB) ependymoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,296: |
Line 2,939: |
| | | | | |
| |- | | |- |
− | |Spinal ependymoma||Disease|| | + | | Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |Spinal ependymoma, MYCN-amplified||Disease||
| |
| | | | | |
| | | | | |
Line 3,312: |
Line 2,948: |
| | | | | |
| |- | | |- |
− | |Myxopapillary ependymoma||Disease|| | + | | Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Subependymoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,328: |
Line 2,957: |
| | | | | |
| |- | | |- |
− | |Choroid plexus papilloma||Disease|| | + | | Primary diffuse large B-cell lymphoma of the CNS||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Atypical choroid plexus papilloma||Disease||
| |
| | | | | |
| | | | | |
Line 3,344: |
Line 2,966: |
| | | | | |
| |- | | |- |
− | |Choroid plexus carcinoma||Disease|| | + | | Immunodeficiency-associated CNS lymphomas||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Medulloblastoma, WNT-activated||Disease||
| |
| | | | | |
| | | | | |
Line 3,360: |
Line 2,975: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| | + | | Lymphomatoid granulomatosis||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Medulloblastoma, SHH-activated and TP53-mutant||Disease||
| |
| | | | | |
| | | | | |
Line 3,376: |
Line 2,984: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, non-WNT/non-SHH||Disease|| | + | | Intravascular large B-cell lymphoma||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |Medulloblastoma, histologically defined||Disease||
| |
| | | | | |
| | | | | |
Line 3,392: |
Line 2,993: |
| | | | | |
| |- | | |- |
− | |Atypical teratoid/rhabdoid tumour||Disease|| | + | | MALT lymphoma of the dura||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Cribriform neuroepithelial tumour||Disease||
| |
| | | | | |
| | | | | |
Line 3,408: |
Line 3,002: |
| | | | | |
| |- | | |- |
− | |Embryonal tumour with multilayered rosettes||Disease|| | + | | Other low-grade B-cell lymphomas of the CNS||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |CNS neuroblastoma, FOXR2-activated||Disease||
| |
| | | | | |
| | | | | |
Line 3,424: |
Line 3,011: |
| | | | | |
| |- | | |- |
− | |CNS tumour with BCOR internal tandem duplication||Disease|| | + | | Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |CNS embryonal tumour NEC/NOS||Disease||
| |
| | | | | |
| | | | | |
Line 3,440: |
Line 3,020: |
| | | | | |
| |- | | |- |
− | |Pineocytoma||Disease|| | + | | T-cell and NK/T-cell lymphomas||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Pineal parenchymal tumour of intermediate differentiation||Disease||
| |
| | | | | |
| | | | | |
Line 3,456: |
Line 3,029: |
| | | | | |
| |- | | |- |
− | |Pineoblastoma||Disease|| | + | | Erdheim-Chester disease||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |Papillary tumour of the pineal region||Disease||
| |
| | | | | |
| | | | | |
Line 3,472: |
Line 3,038: |
| | | | | |
| |- | | |- |
− | |Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| | + | | Rosai-Dorfman disease||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Schwannoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,488: |
Line 3,047: |
| | | | | |
| |- | | |- |
− | |Neurofibroma||Disease|| | + | | Juvenile xanthogranuloma||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Perineurioma||Disease||
| |
| | | | | |
| | | | | |
Line 3,504: |
Line 3,056: |
| | | | | |
| |- | | |- |
− | |Hybrid nerve sheath tumours||Disease|| | + | | Langerhans cell histiocytosis||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Malignant melanotic nerve sheath tumour||Disease||
| |
| | | | | |
| | | | | |
Line 3,520: |
Line 3,065: |
| | | | | |
| |- | | |- |
− | |Malignant peripheral nerve sheath tumour||Disease|| | + | | Histiocytic sarcoma||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
| |
| | | | | |
| | | | | |
Line 3,536: |
Line 3,074: |
| | | | | |
| |- | | |- |
− | |Meningioma||Disease|| | + | | Germ cell tumours of the CNS||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |Solitary fibrous tumour||Disease||
| |
| | | | | |
| | | | | |
Line 3,552: |
Line 3,083: |
| | | | | |
| |- | | |- |
− | |Haemangiomas and vascular malformations||Disease|| | + | | Adamantinomatous craniopharyngioma||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Haemangioblastoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,568: |
Line 3,092: |
| | | | | |
| |- | | |- |
− | |Rhabdomyosarcoma||Disease|| | + | | Papillary craniopharyngioma||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
| |
| | | | | |
| | | | | |
Line 3,584: |
Line 3,101: |
| | | | | |
| |- | | |- |
− | |CIC-rearranged sarcoma||Disease|| | + | | Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Primary intracranial sarcoma, DICER1-mutant||Disease||
| |
| | | | | |
| | | | | |
Line 3,600: |
Line 3,110: |
| | | | | |
| |- | | |- |
− | |Ewing sarcoma||Disease|| | + | | Pituitary adenoma / pituitary neuroendocrine tumour||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Mesenchymal chondrosarcoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,616: |
Line 3,119: |
| | | | | |
| |- | | |- |
− | |Chondrosarcoma||Disease|| | + | | Pituitary blastoma||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |Chordoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,632: |
Line 3,128: |
| | | | | |
| |- | | |- |
− | |Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| | + | | Metastases to the brain and spinal cord parenchyma||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,648: |
Line 3,137: |
| | | | | |
| |- | | |- |
− | |Primary diffuse large B-cell lymphoma of the CNS||Disease|| | + | | Metastases to the meninges||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Immunodeficiency-associated CNS lymphomas||Disease||
| |
| | | | | |
| | | | | |
Line 3,664: |
Line 3,146: |
| | | | | |
| |- | | |- |
− | |Lymphomatoid granulomatosis||Disease|| | + | | Neurofibromatosis type 1||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Intravascular large B-cell lymphoma||Disease||
| |
| | | | | |
| | | | | |
Line 3,680: |
Line 3,155: |
| | | | | |
| |- | | |- |
− | |MALT lymphoma of the dura||Disease|| | + | | Neurofibromatosis type 2||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Other low-grade B-cell lymphomas of the CNS||Disease||
| |
| | | | | |
| | | | | |
Line 3,696: |
Line 3,164: |
| | | | | |
| |- | | |- |
− | |Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| | + | | Schwannomatosis||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |T-cell and NK/T-cell lymphomas||Disease||
| |
| | | | | |
| | | | | |
Line 3,712: |
Line 3,173: |
| | | | | |
| |- | | |- |
− | |Erdheim-Chester disease||Disease|| | + | | Von Hippel-Lindau syndrome||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Rosai-Dorfman disease||Disease||
| |
| | | | | |
| | | | | |
Line 3,728: |
Line 3,182: |
| | | | | |
| |- | | |- |
− | |Juvenile xanthogranuloma||Disease|| | + | | Tuberous sclerosis||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Langerhans cell histiocytosis||Disease||
| |
| | | | | |
| | | | | |
Line 3,744: |
Line 3,191: |
| | | | | |
| |- | | |- |
− | |Histiocytic sarcoma||Disease|| | + | | Li-Fraumeni syndrome||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Germ cell tumours of the CNS||Disease||
| |
| | | | | |
| | | | | |
Line 3,760: |
Line 3,200: |
| | | | | |
| |- | | |- |
− | |Adamantinomatous craniopharyngioma||Disease|| | + | | Cowden syndrome||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Papillary craniopharyngioma||Disease||
| |
| | | | | |
| | | | | |
Line 3,776: |
Line 3,209: |
| | | | | |
| |- | | |- |
− | |Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| | + | | Constitutional mismatch repair deficiency syndrome||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
| |
| | | | | |
| | | | | |
Line 3,792: |
Line 3,218: |
| | | | | |
| |- | | |- |
− | |Pituitary blastoma||Disease|| | + | | Familial adenomatous polyposis 1||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Metastases to the brain and spinal cord parenchyma||Disease||
| |
| | | | | |
| | | | | |
Line 3,808: |
Line 3,227: |
| | | | | |
| |- | | |- |
− | |Metastases to the meninges||Disease|| | + | | Naevoid basal cell carcinoma syndrome||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Neurofibromatosis type 1||Disease||
| |
| | | | | |
| | | | | |
Line 3,824: |
Line 3,236: |
| | | | | |
| |- | | |- |
− | |Neurofibromatosis type 2||Disease|| | + | | Rhabdoid tumour predisposition syndrome||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Schwannomatosis||Disease||
| |
| | | | | |
| | | | | |
Line 3,840: |
Line 3,245: |
| | | | | |
| |- | | |- |
− | |Von Hippel-Lindau syndrome||Disease|| | + | | Carney complex||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Tuberous sclerosis||Disease||
| |
| | | | | |
| | | | | |
Line 3,856: |
Line 3,254: |
| | | | | |
| |- | | |- |
− | |Li-Fraumeni syndrome||Disease|| | + | | DICER1 syndrome||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |Cowden syndrome||Disease||
| |
| | | | | |
| | | | | |
Line 3,872: |
Line 3,263: |
| | | | | |
| |- | | |- |
− | |Constitutional mismatch repair deficiency syndrome||Disease|| | + | | Familial paraganglioma syndromes||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Familial adenomatous polyposis 1||Disease||
| |
| | | | | |
| | | | | |
Line 3,888: |
Line 3,272: |
| | | | | |
| |- | | |- |
− | |Naevoid basal cell carcinoma syndrome||Disease|| | + | | Melanoma-astrocytoma syndrome||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Rhabdoid tumour predisposition syndrome||Disease||
| |
| | | | | |
| | | | | |
Line 3,904: |
Line 3,281: |
| | | | | |
| |- | | |- |
− | |Carney complex||Disease|| | + | | Familial retinoblastoma||Disease|| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |DICER1 syndrome||Disease||
| |
| | | | | |
| | | | | |
Line 3,920: |
Line 3,290: |
| | | | | |
| |- | | |- |
− | |Familial paraganglioma syndromes||Disease|| | + | | BAP1 tumour predisposition syndrome||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |-
| |
− | |Melanoma-astrocytoma syndrome||Disease||
| |
| | | | | |
| | | | | |
Line 3,936: |
Line 3,299: |
| | | | | |
| |- | | |- |
− | |Familial retinoblastoma||Disease|| | + | | Fanconi anaemia||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |-
| |
− | |BAP1 tumour predisposition syndrome||Disease||
| |
| | | | | |
| | | | | |
Line 3,952: |
Line 3,308: |
| | | | | |
| |- | | |- |
− | |Fanconi anaemia||Disease|| | + | | ELP1-medulloblastoma syndrome||Disease|| |
− | |
| |
− | | | |
| | | | | |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |ELP1-medulloblastoma syndrome||Disease||
| |
| | | | | |
| | | | | |
Line 3,968: |
Line 3,317: |
| | | | | |
| |- | | |- |
− | |}
| + | } |